Proteins

Items 131-140 of 199

per page
Set Descending Direction
  1. LIF (human) (rec.)
    AG-40B-0093
    AG-40B-0093-C01010 µg
    CHF 170.00
    AG-40B-0093-30103 x 10 µg
    CHF 335.00
    AG-40B-0093-C100100 µg
    CHF 1'010.00
    Figure: Human Leukemia Inhibitory Factor (LIF) (rec.) (AG-40B-0093) maintains pluripotency of mouse ES cells. Method: Mouse ES oct4 GFP cells were cultured for 3 days in the presence of the indicated concentrations of LIF and followed
  2. LIGHT, Soluble (human) (rec.)
    AG-40B-0009
    AG-40B-0009-C01010 µg
    CHF 145.00
    AG-40B-0009-30103 x 10 µg
    CHF 290.00
  3. Lipocalin-2 (rat) (rec.)
    AG-40A-0108
    AG-40A-0108-C01010 µg
    CHF 190.00
  4. Netrin-1 (human) (rec.)
    AG-40B-0040
    AG-40B-0040-C01010 µg
    CHF 300.00
    AG-40B-0040-30103 x 10 µg
    CHF 600.00
    AG-40B-0040-C100100 µg
    CHF 1'320.00
  5. Netrin-1 (human):Fc (human) (rec.)
    AG-40B-0075
    AG-40B-0075-C01010 µg
    CHF 350.00
    AG-40B-0075-30103 x 10 µg
    CHF 695.00
    AG-40B-0075-C100100 µg
    CHF 1'560.00
    Netrin-1 (human):Fc (human) (rec.) (Prod. No. AG-40B-0075) triggers a DCC-dependent phosphorylation of ERK1/2. Method: HEK 293 cells (Control) or HEK 293 expressing the netrin-1 receptor DCC were incubated with netrin-1 (human):Fc (
  6. NF-κB (p50) (human) (rec.) (His) (highly active)
    AG-40T-0021
    AG-40T-0021-C0022 µg
    CHF 450.00
  7. NF-κB (p65) (human) (rec.) (His) (highly active)
    AG-40T-0020
    AG-40T-0020-C0022 µg
    CHF 390.00
  8. Notch1 (mouse):Fc (human) (rec.)
    AG-40B-0109
    AG-40B-0109-C05050 µg
    CHF 290.00
    AG-40B-0109-30503 x 50 µg
    CHF 575.00
  9. Notch2 (mouse):Fc (human) (rec.)
    AG-40B-0110
    AG-40B-0110-C05050 µg
    CHF 290.00
    AG-40B-0110-30503 x 50 µg
    CHF 575.00
  10. Omentin (human) (rec.)
    AG-40B-0042
    AG-40B-0042-C01010 µg
    CHF 220.00
    AG-40B-0042-30103 x 10 µg
    CHF 455.00

Items 131-140 of 199

per page
Set Descending Direction
© 2017 Adipogen Life Sciences. Pictures: © 2012 Martin Oeggerli. All Rights Reserved.